The Cooper Companies, Inc. Stock Deutsche Boerse AG

Equities

CP60

US2166485019

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 01:31:26 2024-07-17 pm EDT 5-day change 1st Jan Change
83.15 EUR +1.53% Intraday chart for The Cooper Companies, Inc. +4.38% -3.88%
Sales 2024 * 3.89B 3.56B Sales 2025 * 4.15B 3.8B Capitalization 17.95B 16.42B
Net income 2024 * 452M 414M Net income 2025 * 627M 574M EV / Sales 2024 * 5.21 x
Net Debt 2024 * 2.31B 2.11B Net Debt 2025 * 1.81B 1.66B EV / Sales 2025 * 4.76 x
P/E ratio 2024 *
41.4 x
P/E ratio 2025 *
28.6 x
Employees 15,000
Yield 2024 *
0.07%
Yield 2025 *
0.07%
Free-Float 91.34%
More Fundamentals * Assessed data
Dynamic Chart
Trump's unity plea and Powell's perfect pitch propel Wall Street Our Logo
Jefferies Upgrades Cooper Companies to Buy From Hold, Adjusts Price Target to $115 From $107 MT
ANALYST RECOMMENDATIONS : Dollar Tree, JPMorgan, Broadcom, Chipotle, Burberry... Our Logo
Transcript : The Cooper Companies, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 01:30 PM
Transcript : The Cooper Companies, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 10:00 AM
Jefferies Adjusts Price Target on Cooper Companies to $107 From $105 MT
Baird Adjusts Price Target on Cooper Companies to $118 From $116 MT
Transcript : The Cooper Companies, Inc., Q2 2024 Earnings Call, May 30, 2024
Cooper Fiscal Q2 Non-GAAP EPS, Net Sales Rise; Full Year Outlook Raised, Shares Advance MT
The Cooper Companies, Inc. Raises Earnings Guidance for the Fiscal Year 2024 CI
Cooper Companies Guides For FY 2024 EPS of $3.54-$3.60 on Revenue of $3.86-$3.91 Billion, vs CIQ Analyst Consensus of $3.55/Share on Revenue of $3.88 Billion MT
Earnings Flash (COO) COOPERCOMPANIES Posts Q2 Revenue $942.6M MT
The Cooper Companies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 CI
Citigroup Raises Price Target on Cooper Companies to $116 From $108, Keeps Buy Rating MT
Cooper Companies Insider Sold Shares Worth $5,521,230, According to a Recent SEC Filing MT
More news
1 day+1.47%
1 week+4.38%
Current month+0.92%
1 month-5.51%
3 months-3.06%
6 months-5.81%
Current year-3.88%
More quotes
1 week
78.55
Extreme 78.55
83.05
1 month
78.55
Extreme 78.55
85.85
Current year
78.55
Extreme 78.55
94.30
1 year
72.75
Extreme 72.75
94.30
3 years
63.85
Extreme 63.85
97.10
5 years
55.00
Extreme 55
97.10
10 years
27.18
Extreme 27.1763
97.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 06-03-31
Chairman 77 76-12-31
Director of Finance/CFO 45 06-03-31
Members of the board TitleAgeSince
Director/Board Member 67 20-11-30
Director/Board Member 66 Nov. 30
Director/Board Member 72 16-03-31
More insiders
Date Price Change
24-07-17 82.3 +0.49%
24-07-16 81.9 -1.38%
24-07-15 83.05 +2.34%
24-07-12 81.15 +3.31%
24-07-11 78.55 -0.38%

Delayed Quote Deutsche Boerse AG, July 17, 2024 at 02:02 am EDT

More quotes
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
90.14 USD
Average target price
111.5 USD
Spread / Average Target
+23.65%
Consensus